Annual D&A:
$2.18M-$292.00K(-11.83%)Summary
- As of today, STOK annual D&A is $2.18 million, with the most recent change of -$292.00 thousand (-11.83%) on December 31, 2024.
- During the last 3 years, STOK annual D&A has risen by +$1.20 million (+123.51%).
- STOK annual D&A is now -11.83% below its all-time high of $2.47 million, reached on December 31, 2023.
Performance
STOK Depreciation & Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly D&A:
$989.00K-$69.00K(-6.52%)Summary
- As of today, STOK quarterly D&A is $989.00 thousand, with the most recent change of -$69.00 thousand (-6.52%) on September 30, 2025.
- Over the past year, STOK quarterly D&A has dropped by -$122.00 thousand (-10.98%).
- STOK quarterly D&A is now -18.60% below its all-time high of $1.22 million, reached on December 31, 2023.
Performance
STOK Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$4.23M-$122.00K(-2.80%)Summary
- As of today, STOK TTM D&A is $4.23 million, with the most recent change of -$122.00 thousand (-2.80%) on September 30, 2025.
- Over the past year, STOK TTM D&A has dropped by -$318.00 thousand (-6.99%).
- STOK TTM D&A is now -10.53% below its all-time high of $4.73 million, reached on December 31, 2023.
Performance
STOK TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
STOK Depreciation & Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -11.8% | -11.0% | -7.0% |
| 3Y3 Years | +123.5% | +7.0% | +40.9% |
| 5Y5 Years | +383.8% | +99.4% | +170.9% |
STOK Depreciation & Amortization Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -11.8% | +123.5% | -18.6% | +7.0% | -10.5% | +40.9% |
| 5Y | 5-Year | -11.8% | +383.8% | -18.6% | +99.4% | -10.5% | +170.9% |
| All-Time | All-Time | -11.8% | +1826.5% | -18.6% | +2990.6% | -10.5% | >+9999.0% |
STOK Depreciation & Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $989.00K(-6.5%) | $4.23M(-2.8%) |
| Jun 2025 | - | $1.06M(-1.7%) | $4.35M(-1.2%) |
| Mar 2025 | - | $1.08M(-2.9%) | $4.41M(-0.8%) |
| Dec 2024 | $2.18M(-11.8%) | $1.11M(-0.3%) | $4.44M(-2.4%) |
| Sep 2024 | - | $1.11M(+0.1%) | $4.55M(-1.9%) |
| Jun 2024 | - | $1.11M(-0.3%) | $4.64M(-1.2%) |
| Mar 2024 | - | $1.11M(-8.4%) | $4.70M(-0.7%) |
| Dec 2023 | $2.47M(+59.7%) | $1.22M(+1.3%) | $4.73M(+1.4%) |
| Sep 2023 | - | $1.20M(+2.8%) | $4.67M(+6.3%) |
| Jun 2023 | - | $1.17M(+1.7%) | $4.39M(+8.2%) |
| Mar 2023 | - | $1.15M(-0.4%) | $4.06M(+14.8%) |
| Dec 2022 | $1.55M(+58.7%) | $1.15M(+24.7%) | $3.54M(+17.7%) |
| Sep 2022 | - | $924.00K(+10.7%) | $3.00M(+13.1%) |
| Jun 2022 | - | $835.00K(+33.8%) | $2.66M(+13.2%) |
| Mar 2022 | - | $624.00K(+0.5%) | $2.35M(+5.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | $974.00K(+9.7%) | $621.00K(+7.8%) | $2.23M(+5.6%) |
| Sep 2021 | - | $576.00K(+9.5%) | $2.11M(+3.9%) |
| Jun 2021 | - | $526.00K(+3.7%) | $2.03M(-9.3%) |
| Mar 2021 | - | $507.00K(+0.8%) | $2.24M(+16.3%) |
| Dec 2020 | $888.00K(+97.3%) | $503.00K(+1.4%) | $1.93M(+23.3%) |
| Sep 2020 | - | $496.00K(-32.4%) | $1.56M(+31.0%) |
| Jun 2020 | - | $734.00K(+280.3%) | $1.19M(+111.7%) |
| Mar 2020 | - | $193.00K(+38.8%) | $563.00K(+25.1%) |
| Dec 2019 | $450.00K(+110.3%) | $139.00K(+10.3%) | $450.00K(+44.7%) |
| Sep 2019 | - | $126.00K(+20.0%) | $311.00K(+68.1%) |
| Jun 2019 | - | $105.00K(+31.3%) | $185.00K(+131.3%) |
| Mar 2019 | - | $80.00K(+150.0%) | $80.00K(+150.0%) |
| Dec 2018 | $214.00K(+89.4%) | - | - |
| Mar 2018 | - | $32.00K | $32.00K |
| Dec 2017 | $113.00K | - | - |
FAQ
- What is Stoke Therapeutics, Inc. annual D&A?
- What is the all-time high annual D&A for Stoke Therapeutics, Inc.?
- What is Stoke Therapeutics, Inc. annual D&A year-on-year change?
- What is Stoke Therapeutics, Inc. quarterly D&A?
- What is the all-time high quarterly D&A for Stoke Therapeutics, Inc.?
- What is Stoke Therapeutics, Inc. quarterly D&A year-on-year change?
- What is Stoke Therapeutics, Inc. TTM D&A?
- What is the all-time high TTM D&A for Stoke Therapeutics, Inc.?
- What is Stoke Therapeutics, Inc. TTM D&A year-on-year change?
What is Stoke Therapeutics, Inc. annual D&A?
The current annual D&A of STOK is $2.18M
What is the all-time high annual D&A for Stoke Therapeutics, Inc.?
Stoke Therapeutics, Inc. all-time high annual D&A is $2.47M
What is Stoke Therapeutics, Inc. annual D&A year-on-year change?
Over the past year, STOK annual D&A has changed by -$292.00K (-11.83%)
What is Stoke Therapeutics, Inc. quarterly D&A?
The current quarterly D&A of STOK is $989.00K
What is the all-time high quarterly D&A for Stoke Therapeutics, Inc.?
Stoke Therapeutics, Inc. all-time high quarterly D&A is $1.22M
What is Stoke Therapeutics, Inc. quarterly D&A year-on-year change?
Over the past year, STOK quarterly D&A has changed by -$122.00K (-10.98%)
What is Stoke Therapeutics, Inc. TTM D&A?
The current TTM D&A of STOK is $4.23M
What is the all-time high TTM D&A for Stoke Therapeutics, Inc.?
Stoke Therapeutics, Inc. all-time high TTM D&A is $4.73M
What is Stoke Therapeutics, Inc. TTM D&A year-on-year change?
Over the past year, STOK TTM D&A has changed by -$318.00K (-6.99%)